Advances for Memory Loss, Dementia and Alzheimer’s - First Choice Neurology - Jeffrey Gelblum, MD

Memory Loss: Dementia and Alzheimer’s Disease

Could an amyloid-targeting therapy finally be poised for approval? For more than a quarter-century, researchers have targeted amyloid, a protein that clogs the brains of many Alzheimer’s patients. It was first spotted by Alois Alzheimer in 1906 but didn’t become the focus of drug companies until forms of the disease were linked to amyloid buildup in the 1990s.

Neurologist and Study Investigator, Jeffrey Gelblum, MD, talks about disease-modifying treatments for memory loss, dementia, and Alzheimer’s disease.

#alzheimers #firstchoiceneurology #drjeffreygelblum

Видео Advances for Memory Loss, Dementia and Alzheimer’s - First Choice Neurology - Jeffrey Gelblum, MD канала First Choice Neurology